Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02766907 · ClinicalTrials.gov registry record · NA
Optimizing the Ocular Surface Prior to Cataract Surgery
A NA study, sponsored by BioTissue Holdings.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02766907: Completed NA study, sponsored by BioTissue Holdings.
NCT02766907 is a NA study that has completed, run by BioTissue Holdings. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02766907, a NA study, has completed, sponsored by BioTissue Holdings.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Prospective study to evaluate the efficacy of using self-retained cryopreserved amniotic membrane after debridement in treating Epithelial Base Membrane Dystrophy (EBMD) to optimize the ocular surface integrity and intraocular lens calculation before cataract surgery.
Primary Outcome
Assessed by corneal topography
Interventions
- DEVICE cryopreserved amniotic membrane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-03 |
| Est. Completion | 2018-04 |
| Phase | NA |
What the finished NCT02766907 record still lists
NCT02766907 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which cryopreserved amniotic membrane is the first listed.
NCT02766907 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02766907 about?
NCT02766907 is a clinical study titled "Optimizing the Ocular Surface Prior to Cataract Surgery". Prospective study to evaluate the efficacy of using self-retained cryopreserved amniotic membrane after debridement in treating Epithelial Base Membrane Dystrophy (EBMD) to optimize the ocular surface integrity and intraocular lens calculation before cataract surgery.
What is the current status of trial NCT02766907?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-03. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02766907?
The interventions under investigation include: cryopreserved amniotic membrane (DEVICE).
Who is sponsoring clinical trial NCT02766907?
This trial is sponsored by BioTissue Holdings, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02766907's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia